BiotechTube
Home/Trutino Biosciences/Hsieng Lu
HL

Hsieng Lu

Chief Development Advisor

Trutino Biosciences

Therapeutic Areas

OncologyAutoimmune Diseases

Trutino Biosciences Pipeline

DrugIndicationPhase
Lead Zytokine ProgramSolid TumorsIND Approved / Phase 1 Planned

Leadership Team at Trutino Biosciences

PK
Phillip Kim
CEO, Chairman of the Board
EL
Emma Langley
COO, VP Research & Development
MR
Maria Ramirez
Head, Clinical Development
View full Trutino Biosciences profile